值班冷沉淀:病原体灭活冷沉淀纤维蛋白原复合物与创伤出血患者纤维蛋白原补充改善相关
这项单中心回顾性研究比较了IFC实施前后各1年、共294例1小时内接受>900 mL红细胞和/或全血(达到临界给药阈值)的成人创伤患者。IFC实施后患者更年长、钝性伤更多、休克指数更低、全血使用率更高、4小时输血量更低。校正差异后,IFC实施与纤维蛋白原补充可能性增加独立相关(校正OR 2.45,95%CI 1.05-5.74),但与24小时死亡率或4小时输血需求无关。纤维蛋白原补充时机有提前趋势但未达统计学显著(中位67 vs 42分钟,p=0.070)。作者认为低纤维蛋白原血症的出血患者可能从IFC获益。
要点
- 在1级创伤中心,IFC实施与纤维蛋白原补充可能性增加独立相关(校正OR 2.45,95%CI 1.05-5.74)。
- IFC实施与24小时死亡率或4小时输血需求无关。
- 纤维蛋白原补充时机有提前趋势但未达统计学显著:中位67 vs 42分钟(p=0.070),60分钟内补充率40.0% vs 63.4%(p=0.051)。
- IFC实施后4小时输血量更低(2.0 vs 2.4 L,p=0.027),但校正后无独立关联。
- 作者认为低纤维蛋白原血症的出血患者可能从IFC获益。
适用人群与场景
- 成人创伤患者,1小时内接受>900 mL红细胞和/或全血(达到临界给药阈值,提示显著出血),不排除以全血为主要复苏方式者。
诊断标准与关键阈值
- 临界给药阈值:1小时内接受>900 mL红细胞和/或全血。
研究设计与关键结果
- 单中心回顾性研究,纳入294例成人创伤患者,比较IFC实施前1年与实施后1年。
- IFC实施后患者更年长(44 vs 39岁,p=0.011)、钝性伤更多(67.5% vs 53.6%,p=0.009)、休克指数更低(0.87 vs 0.99,p=0.004)、全血使用率更高(72.1% vs 37.9%,p<0.001)、4小时输血量更低(2.0 vs 2.4 L,p=0.027),ISS、GCS、碱缺失和血细胞比容相似。
- 纤维蛋白原补充率24.1%(IFC前21.4% vs IFC后26.6%,p=0.299)。
- 校正差异后,IFC实施与纤维蛋白原补充可能性增加独立相关(校正OR 2.45,95%CI 1.05-5.74),但与24小时死亡率或4小时输血需求无关。
- 纤维蛋白原补充时机有提前趋势但未达统计学显著:中位67 vs 42分钟(p=0.070),60分钟内补充率40.0% vs 63.4%(p=0.051)。
证据类型、等级与局限
- 证据类型:单中心回顾性研究;证据等级:预后与流行病学,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- IFC可 thawed 储存长达5天,允许立即使用,可能缩短纤维蛋白原补充时间,但本研究未达统计学显著。
- IFC实施与纤维蛋白原补充可能性增加独立相关,但与死亡率或输血需求无关。
- 作者认为低纤维蛋白原血症的出血患者可能从IFC获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Fibrinogen supplementation (FS) is commonly achieved with cryoprecipitate, although the required on-demand thawing often results in delayed FS. Pathogen-reduced cryoprecipitated fibrinogen complex (INTERCEPT fibrinogen complex [IFC]), a novel product, can be stored thawed for up to 5 days, allowing for immediate availability. We hypothesized that IFC implementation at our level 1 trauma center would be associated with increased likelihood of FS, decreased mortality, and transfusion requirement (TR).
METHODS: This was a retrospective review from a single level 1 trauma center from 2022 to 2024, spanning 1 year pre- and post-IFC implementation. Adults who received >900 mL of red blood cells and/or whole blood (WB) within 1 hour were included to identify patients who reached critical administration threshold, indicating significant hemorrhage, without excluding those being resuscitated primarily with WB. Multiple logistic regression assessed the independent effect of IFC implementation on the likelihood of FS and 24-hour mortality. Linear regression modeled TR.
RESULTS: In 294 included patients, 24.1% received FS (21.4% pre-IFC, 26.6% post-IFC, p = 0.299). Post-IFC patients tended to be older (44 vs. 39, p = 0.011) and had blunt trauma more often (67.5% vs. 53.6%, p = 0.009), lower shock index (0.87 vs. 0.99, p = 0.004), higher rates of WB use (72.1% vs. 37.9%, p < 0.001), and lower 4-hour TR (2.0 vs. 2.4 L, p = 0.027) but similar ISS, GCS, base deficit, and hematocrit. After controlling for these differences, IFC implementation was associated with increased likelihood of FS (adjusted odds ratio, 2.45; 95% confidence interval, 1.05-5.74), but not with 24-hour mortality or 4-hour TR. Although not statistically significant, there was a trend to earlier FS (median, 67 vs. 42 minutes; p = 0.070; rates of FS within 60 minutes, 40.0% vs. 63.4%; p = 0.051).
CONCLUSION: INTERCEPT fibrinogen complex implementation at our level 1 trauma center was independently associated with FS, but not mortality or TR. Hemorrhaging patients with hypofibrinogenemia, a time-sensitive predictor of mortality in trauma, may benefit from IFC.
LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level III.
参考来源
- Cobler-Lichter MD, Arcieri TR, Brochu BM, et al. Cryo on call: Pathogen-reduced cryoprecipitated fibrinogen complex is associated with improved fibrinogen supplementation in hemorrhaging trauma patients. J Trauma Acute Care Surg. 2025. PMID: 41417676. doi:10.1097/TA.0000000000004846
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。